HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne B Rossebø Selected Research

Ezetimibe (Zetia)

1/2022Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.
1/2021Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis.
11/2017Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.
1/2017Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis.
11/2015Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
2/2015Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
9/2014Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
8/2014Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
7/2014Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
1/2014Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne B Rossebø Research Topics

Disease

25Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 04/2007
4Atrial Fibrillation
07/2014 - 04/2012
3Stroke (Strokes)
07/2014 - 09/2008
2Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2017 - 03/2012
2Unstable Angina
10/2012 - 09/2008
2Myocardial Infarction
10/2012 - 09/2008
2Heart Failure
10/2012 - 09/2008
2Hypertrophy
01/2012 - 08/2011
1Obesity
05/2010
1Pathologic Constriction (Stenosis)
09/2008
1Hyperlipidemias (Hyperlipidemia)
09/2008
1Neoplasms (Cancer)
09/2008

Drug/Important Bio-Agent (IBA)

25Simvastatin (Zocor)FDA LinkGeneric
01/2022 - 04/2007
25Ezetimibe (Zetia)FDA Link
01/2022 - 04/2007
3LipidsIBA
04/2012 - 04/2007
1pro-brain natriuretic peptide (1-76)IBA
01/2022
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022
1Antihypertensive Agents (Antihypertensives)IBA
11/2017
1AntioxidantsIBA
04/2012
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2012
1DiureticsIBA
08/2011
1Digoxin (Digitek)FDA LinkGeneric
08/2011
1CalciumIBA
08/2011
1Uric Acid (Urate)IBA
08/2011
1Blood Glucose (Blood Sugar)IBA
08/2011
1Anti-Arrhythmia AgentsIBA
08/2011
1LDL CholesterolIBA
06/2010
1Lipoproteins (Lipoprotein)IBA
06/2010
1IceIBA
06/2010

Therapy/Procedure

3Therapeutics
11/2017 - 04/2007
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
07/2014 - 09/2008
2Percutaneous Coronary Intervention
10/2012 - 09/2008